Published in J Immunol Methods on August 09, 1993
Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J Exp Med (1996) 0.90
An insulin peptide that binds an alternative site in class II major histocompatibility complex. J Exp Med (1996) 0.89
Membrane interactions influence the peptide binding behavior of DR1. J Exp Med (1994) 0.80
A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination. J Immunol Methods (2014) 0.79
Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization. Curr Protoc Immunol (2014) 0.78
Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. Eur J Immunol (2016) 0.76
A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule. Sci Rep (2017) 0.75
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Engineering the third wave of biocatalysis. Nature (2012) 3.44
Energetics, patterns of interaction strengths, and stability in real ecosystems. Science (1995) 3.17
Formation of plant RNA virus replication complexes on membranes: role of an endoplasmic reticulum-targeted viral protein. EMBO J (1997) 2.99
Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet (1992) 2.95
Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood (2000) 2.78
Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science (1996) 2.68
Acute toxicity, bioconcentration, and persistence of AC 222,705, benthiocarb, chlorpyrifos, fenvalerate, methyl parathion, and permethrin in the estuarine environment. J Agric Food Chem (1983) 2.65
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis (1985) 2.61
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol (2000) 2.50
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22
DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity (1995) 2.10
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine (1995) 1.83
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
The PSI-H subunit of photosystem I is essential for state transitions in plant photosynthesis. Nature (2000) 1.77
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost (2008) 1.75
Combining metabolic engineering and metabolic evolution to develop nonrecombinant strains of Escherichia coli C that produce succinate and malate. Biotechnol Bioeng (2008) 1.73
Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis (1998) 1.73
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
The operant manipulation of vocal pitch in normal speakers. J Speech Hear Res (1971) 1.63
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
Eliminating side products and increasing succinate yields in engineered strains of Escherichia coli C. Biotechnol Bioeng (2008) 1.50
Balance of power: a view of the mechanism of photosynthetic state transitions. Trends Plant Sci (2001) 1.49
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
A genetic screen for vascular mutants in zebrafish reveals dynamic roles for Vegf/Plcg1 signaling during artery development. Dev Biol (2009) 1.45
Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol (2005) 1.45
New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42
Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol (1999) 1.38
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Molecular characterization of measles viruses isolated in Victoria, Australia, between 1973 and 1998. J Gen Virol (2000) 1.32
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31
Production of L -alanine by metabolically engineered Escherichia coli. Appl Microbiol Biotechnol (2007) 1.30
Early motion of the ankle after operative treatment of a rupture of the Achilles tendon. A prospective, randomized clinical and radiographic study. J Bone Joint Surg Am (1999) 1.29
Role of subunits in eukaryotic Photosystem I. Biochim Biophys Acta (2001) 1.28
Genetic evidence for an essential role for potyvirus CI protein in cell-to-cell movement. Plant J (1998) 1.28
A putative Mg chelatase subunit from Arabidopsis thaliana cv C24. Sequence and transcript analysis of the gene, import of the protein into chloroplasts, and in situ localization of the transcript and protein. Plant Physiol (1996) 1.26
Cloning, sequencing and functional assignment of the chlorophyll biosynthesis gene, chlP, of Synechocystis sp. PCC 6803. FEBS Lett (1996) 1.24
Supermolecular organization of photosystem II and its associated light-harvesting antenna in Arabidopsis thaliana. Eur J Biochem (2001) 1.24
Stepped care for back pain: activating approaches for primary care. Ann Intern Med (2001) 1.24
Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis (2000) 1.23
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23
Modelling food webs and nutrient cycling in agro-ecosystems. Trends Ecol Evol (1994) 1.18
Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18
Green plant photosystem I binds light-harvesting complex I on one side of the complex. Biochemistry (2001) 1.17
Influence of productivity on the stability of real and model ecosystems. Science (1993) 1.16
Oregon subduction zone: venting, fauna, and carbonates. Science (1986) 1.16
Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med (1984) 1.12
Skiing injuries in children and adolescents. J Trauma (1996) 1.11
Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry (2000) 1.10
Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08
The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08
A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol (1999) 1.08
C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine (2001) 1.08
An evaluation of the use of colonized periphyton as an indicator of wastewater impact in near-coastal areas of the Gulf of Mexico. Arch Environ Contam Toxicol (2002) 1.08
Magnesium chelatase from Rhodobacter sphaeroides: initial characterization of the enzyme using purified subunits and evidence for a BchI-BchD complex. Biochem J (1999) 1.07
Minor role for direct adrenoceptor-mediated calcium entry in rat mesenteric small arteries. J Vasc Res (1995) 1.07
Virology of measles virus. J Infect Dis (1994) 1.06
Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis (1994) 1.05
Optimizing industrial enzymes by directed evolution. Adv Biochem Eng Biotechnol (1997) 1.04
Genetics of insulin-specific helper and suppressor T cells in nonresponder mice. J Immunol (1985) 1.03
Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03
Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b). J Exp Med (1998) 1.02
Structure and expression of a nitrite reductase gene from bean (Phaseolus vulgaris) and promoter analysis in transgenic tobacco. Plant Mol Biol (1995) 1.02
Reconstitution of an active magnesium chelatase enzyme complex from the bchI, -D, and -H gene products of the green sulfur bacterium Chlorobium vibrioforme expressed in Escherichia coli. J Bacteriol (1998) 1.02
Congenital anomalies of the optic disk. Am J Ophthalmol (1976) 1.01
Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol (2009) 1.01
Malignant phyllodes tumor of the prostate. A case report with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med (1992) 1.00
Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J Immunol (2001) 0.98
Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood (1992) 0.97
A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J Exp Med (1996) 0.97
Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine. J Gen Virol (1993) 0.97
Measles genotype G2 in Indonesia and Malaysia. Lancet (2000) 0.96
Glycosylated haemoglobin: comparison of five different methods, including measurement on capillary blood samples. Ann Clin Biochem (1986) 0.96
Dredging impact on an urbanized Florida bayou: effects on benthos and algal-periphyton. Environ Pollut (2001) 0.96
Human ocular mucus. Chemical studies. Exp Eye Res (1981) 0.95
A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules. Int Immunol (1997) 0.95
Effect of acidosis on tension and [Ca2+]i in rat cerebral arteries: is there a role for membrane potential? Am J Physiol (1998) 0.94
Traumatic transdiaphragmatic intercostal hernia secondary to coughing: case report and review of the literature. J Trauma (1996) 0.93
The unimportance of being (protein kinase C) epsilon. FASEB J (1998) 0.93
Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol (1999) 0.92
Monitoring progress toward measles elimination by genetic diversity analysis of measles viruses in China 2009-2010. Clin Microbiol Infect (2014) 0.90
Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J Exp Med (1996) 0.90
Bystander help in primary immune responses in vivo. J Exp Med (1986) 0.90
An insulin peptide that binds an alternative site in class II major histocompatibility complex. J Exp Med (1996) 0.89
Persistent left superior vena cava and associated structural and functional considerations. Angiology (1981) 0.88
Effect of decreased O2 supply to tissue on the lactate: pyruvate ratio in blood. J Clin Invest (1969) 0.88
Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology (1997) 0.87
Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol (1999) 0.87
Inefficient peptide binding by cell-surface class II MHC molecules. Cell Immunol (1997) 0.87